A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
The purpose of the study is to learn about the safety, tolerability (the extent to which side effects can be tolerated), and plasma pharmacokinetics (PK) (PK helps us understand how the drug is changed and eliminated from body after you take it) of PF-07291177 after administration of escalating, single, doses by mouth.
Epistemonikos ID: 5f68c03a97ece2b683ea8afc007518255588af29
First added on: Oct 02, 2023